Premium
Letter: intestinal inflammation, COVID‐19 and gastrointestinal ACE2—exploring RAS inhibitors. Authors’ reply
Author(s) -
Taxonera Carlos,
Sagastagoitia Iñigo,
Alba Cristina,
Mañas Norberto,
Olivares David,
Rey Enrique
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15893
Subject(s) - covid-19 , medicine , inflammation , coronavirus infections , medline , virology , biology , biochemistry , disease , outbreak , infectious disease (medical specialty)